Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Newly diagnosed chemotherapy Naïve Patients with Multiple Myeloma at Risk for Cancer-associated Thrombosis. The Observational ROADMAP-CAT-MM Study
Titel:
Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Newly diagnosed chemotherapy Naïve Patients with Multiple Myeloma at Risk for Cancer-associated Thrombosis. The Observational ROADMAP-CAT-MM Study
Auteur:
Fotiou, D. Papageorgiou, L. Salta, S. Terpos, E. Fareed, J. VanDreden, P. Lefkou, E. Larsen, A.K. Elalamy, I. Dimopoulos, M.A. Gerotziafas, G.T.